ARMP

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Armata Pharmaceuticals Inc

NYSE MKT | ARMP

2.93

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 17, 2025)

$104.35M

Market Cap

-

P/E Ratio

-1.07

EPS

$3.14

52 Week High

$0.90

52 Week Low

HEALTHCARE

Sector

ARMP Chart

Recent Chart
Price Action

ARMP Technicals

Tags:

ARMP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.8M
Total Revenue $5.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $48M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$6.8M
Net Income -$19M

Revenue & Profitability

Earnings Performance

ARMP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $86M
Total Current Assets $11M
Cash And Cash Equivalents At Carrying Value $9.3M
Cash And Short Term Investments $9.3M
Inventory -
Current Net Receivables $744K
Total Non Current Assets $75M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $10M
Intangible Assets Excluding Goodwill $10M
Goodwill $3.5M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $134M
Total Current Liabilities $48M
Current Accounts Payable $766K
Deferred Revenue -
Current Debt -
Short Term Debt $43M
Total Non Current Liabilities $86M
Capital Lease Obligations $32M
Long Term Debt $55M
Current Long Term Debt $39M
Long Term Debt Noncurrent -
Short Long Term Debt Total $127M
Other Current Liabilities $4.1M
Other Non Current Liabilities -
Total Shareholder Equity -$48M
Treasury Stock -
Retained Earnings -$328M
Common Stock $362K
Common Stock Shares Outstanding $59M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$38M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $1.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.9M
Cashflow From Financing $35M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.8M
Total Revenue $5.2M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $48M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$6.8M
Net Income -$19M

ARMP Profile

Armata Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Armata Pharmaceuticals Inc. is a clinical-stage biotechnology company headquartered in Marina del Rey, California, dedicated to innovating bacteriophage-based therapies aimed at combating antibiotic-resistant infections globally. Leveraging cutting-edge technology and extensive research, the company is at the forefront of addressing critical needs in infectious disease treatment, with a strong emphasis on precision medicine. With a promising pipeline and strategic partnerships, Armata is positioned to make a significant impact in the field of antimicrobial therapies, contributing to a vital solution in the ongoing battle against antibiotic resistance.

CGBS
-39.47%
$0.03
CDT
+35.45%
$0.86
SPRC
+123.90%
$4.11
NFE
+26.22%
$2.52
ATCH
+47.02%
$1.27
PLUG
+12.54%
$1.89
KDLY
+20.96%
$1.50
GV
+75.37%
$2.92
NVDA
-2.50%
$170.50
NUAI
+2.36%
$0.48
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
NIO
+3.98%
$7.30
LYFT
+13.71%
$22.96
BITF
+1.03%
$2.91
LYT
-16.77%
$0.09
IPM
+22.53%
$2.36
SNAP
+2.51%
$7.93
MULN
-12.58%
$0.06
TNMG
+16.12%
$0.38
PGRE
-11.51%
$6.53
QBTS
+9.27%
$20.74
TSLA
-0.72%
$418.58
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
GRAB
-5.37%
$5.98
ADAP
-5.25%
$0.07
SRM
+53.27%
$10.30
KEY
-1.11%
$18.63
RELI
+10.11%
$0.75
MARA
-0.31%
$17.47
NWTN
+12.58%
$1.70
CWD
+23.93%
$7.87
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTI
+3.20%
$20.64
WLGS
-5.57%
$0.04
PLTR
-3.32%
$164.59
RR
+2.97%
$3.98
SOUN
+1.30%
$14.88
ETWO
0.00%
$3.30
F
+1.21%
$11.75
AAL
+2.25%
$12.69
DNN
+1.20%
$2.52
AFMD
-34.94%
$0.18
SOFI
-1.51%
$27.00
IONQ
+3.18%
$64.23
BMNR
-0.10%
$55.87
BINI
-8.48%
$0.06
PFE
+1.21%
$24.19
NAKA
+4.00%
$1.56
ATYR
-6.48%
$1.01
UBER
-5.16%
$92.78
PEB
+2.72%
$11.87
INTC
-1.22%
$24.96
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AIRE
+10.62%
$1.40
LITM
0.00%
$4.12
RIVN
+0.84%
$14.44
RIOT
+1.34%
$17.75
NOK
+2.16%
$4.71
CPNG
-0.56%
$33.31
QS
+4.08%
$10.56
JOBY
-2.44%
$14.03
BURU
+0.21%
$0.13
FAAS
+9.89%
$0.10
RAYA
-4.05%
$0.04
ASTI
+13.29%
$2.20
ACHR
+0.20%
$9.12
RZLV
-0.93%
$7.28
BTG
+1.61%
$4.38
DVLT
-12.33%
$0.39
AMD
-0.66%
$159.40
WMT
-0.26%
$103.42
CODX
-26.36%
$0.47
GOOGL
-1.39%
$247.66
VALE
-0.50%
$10.85
RIG
-0.14%
$3.46
ZAPP
-46.30%
$0.15
OPI
-3.99%
$0.79
JD
+1.16%
$35.11
WBD
-1.78%
$17.92
BABA
+2.29%
$165.93
BBD
+1.97%
$3.27
AMZN
-1.45%
$230.64
WULF
+1.54%
$11.10
AAPL
+0.45%
$239.23
TLRY
-2.04%
$1.19
INFY
+3.60%
$17.67
CAN
-1.07%
$0.79
PDD
+3.63%
$133.75
BTE
-2.29%
$2.54
LDI
+7.53%
$4.77
OSCR
-2.60%
$17.46
MRVL
+2.88%
$70.84
SQFT
+33.08%
$8.07
ORCL
-3.02%
$297.37
BIAF
-32.91%
$0.17
IONZ
-5.42%
$5.05
CGBS
-39.47%
$0.03
CDT
+35.45%
$0.86
SPRC
+123.90%
$4.11
NFE
+26.22%
$2.52
ATCH
+47.02%
$1.27
PLUG
+12.54%
$1.89
KDLY
+20.96%
$1.50
GV
+75.37%
$2.92
NVDA
-2.50%
$170.50
NUAI
+2.36%
$0.48
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
NIO
+3.98%
$7.30
LYFT
+13.71%
$22.96
BITF
+1.03%
$2.91
LYT
-16.77%
$0.09
IPM
+22.53%
$2.36
SNAP
+2.51%
$7.93
MULN
-12.58%
$0.06
TNMG
+16.12%
$0.38
PGRE
-11.51%
$6.53
QBTS
+9.27%
$20.74
TSLA
-0.72%
$418.58
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
GRAB
-5.37%
$5.98
ADAP
-5.25%
$0.07
SRM
+53.27%
$10.30
KEY
-1.11%
$18.63
RELI
+10.11%
$0.75
MARA
-0.31%
$17.47
NWTN
+12.58%
$1.70
CWD
+23.93%
$7.87
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTI
+3.20%
$20.64
WLGS
-5.57%
$0.04
PLTR
-3.32%
$164.59
RR
+2.97%
$3.98
SOUN
+1.30%
$14.88
ETWO
0.00%
$3.30
F
+1.21%
$11.75
AAL
+2.25%
$12.69
DNN
+1.20%
$2.52
AFMD
-34.94%
$0.18
SOFI
-1.51%
$27.00
IONQ
+3.18%
$64.23
BMNR
-0.10%
$55.87
BINI
-8.48%
$0.06
PFE
+1.21%
$24.19
NAKA
+4.00%
$1.56
ATYR
-6.48%
$1.01
UBER
-5.16%
$92.78
PEB
+2.72%
$11.87
INTC
-1.22%
$24.96
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AIRE
+10.62%
$1.40
LITM
0.00%
$4.12
RIVN
+0.84%
$14.44
RIOT
+1.34%
$17.75
NOK
+2.16%
$4.71
CPNG
-0.56%
$33.31
QS
+4.08%
$10.56
JOBY
-2.44%
$14.03
BURU
+0.21%
$0.13
FAAS
+9.89%
$0.10
RAYA
-4.05%
$0.04
ASTI
+13.29%
$2.20
ACHR
+0.20%
$9.12
RZLV
-0.93%
$7.28
BTG
+1.61%
$4.38
DVLT
-12.33%
$0.39
AMD
-0.66%
$159.40
WMT
-0.26%
$103.42
CODX
-26.36%
$0.47
GOOGL
-1.39%
$247.66
VALE
-0.50%
$10.85
RIG
-0.14%
$3.46
ZAPP
-46.30%
$0.15
OPI
-3.99%
$0.79
JD
+1.16%
$35.11
WBD
-1.78%
$17.92
BABA
+2.29%
$165.93
BBD
+1.97%
$3.27
AMZN
-1.45%
$230.64
WULF
+1.54%
$11.10
AAPL
+0.45%
$239.23
TLRY
-2.04%
$1.19
INFY
+3.60%
$17.67
CAN
-1.07%
$0.79
PDD
+3.63%
$133.75
BTE
-2.29%
$2.54
LDI
+7.53%
$4.77
OSCR
-2.60%
$17.46
MRVL
+2.88%
$70.84
SQFT
+33.08%
$8.07
ORCL
-3.02%
$297.37
BIAF
-32.91%
$0.17
IONZ
-5.42%
$5.05
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.